EP0905138A1 - Cristaux de maltitol de formes particulières, compositions cristallines les contenant et procédés pour leur préparation - Google Patents
Cristaux de maltitol de formes particulières, compositions cristallines les contenant et procédés pour leur préparation Download PDFInfo
- Publication number
- EP0905138A1 EP0905138A1 EP98402334A EP98402334A EP0905138A1 EP 0905138 A1 EP0905138 A1 EP 0905138A1 EP 98402334 A EP98402334 A EP 98402334A EP 98402334 A EP98402334 A EP 98402334A EP 0905138 A1 EP0905138 A1 EP 0905138A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- maltitol
- equal
- crystals
- maltotriitol
- preferably greater
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000010449 maltitol Nutrition 0.000 title claims abstract description 110
- 239000000845 maltitol Substances 0.000 title claims abstract description 109
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 title claims abstract description 93
- 229940035436 maltitol Drugs 0.000 title claims abstract description 87
- 239000013078 crystal Substances 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims description 19
- 238000002360 preparation method Methods 0.000 title abstract description 3
- XJCCHWKNFMUJFE-CGQAXDJHSA-N Maltotriitol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 XJCCHWKNFMUJFE-CGQAXDJHSA-N 0.000 claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 abstract description 14
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 25
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 25
- 229920002472 Starch Polymers 0.000 description 12
- 235000019698 starch Nutrition 0.000 description 12
- 239000008107 starch Substances 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 230000008025 crystallization Effects 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 235000020357 syrup Nutrition 0.000 description 11
- 239000006188 syrup Substances 0.000 description 11
- 108090000637 alpha-Amylases Proteins 0.000 description 10
- 238000005984 hydrogenation reaction Methods 0.000 description 10
- 235000013336 milk Nutrition 0.000 description 9
- 239000008267 milk Substances 0.000 description 9
- 210000004080 milk Anatomy 0.000 description 9
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 8
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 8
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 8
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 102000004139 alpha-Amylases Human genes 0.000 description 7
- 229940024171 alpha-amylase Drugs 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 229920001542 oligosaccharide Polymers 0.000 description 7
- 150000002482 oligosaccharides Chemical class 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000007873 sieving Methods 0.000 description 7
- 101710117655 Maltogenic alpha-amylase Proteins 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- LUAHEUHBAZYUOI-KVXMBEGHSA-N (2s,3r,4r,5r)-4-[(2r,3r,4r,5s,6r)-5-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 LUAHEUHBAZYUOI-KVXMBEGHSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010028688 Isoamylase Proteins 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 108010019077 beta-Amylase Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 235000019219 chocolate Nutrition 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 229920002245 Dextrose equivalent Polymers 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- -1 fatty acid esters Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 235000012839 cake mixes Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000414 polyfuran Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 108010075550 termamyl Proteins 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Definitions
- the present invention relates to crystals of maltitol of particular forms and compositions containing them. It also relates to a particular process for obtaining these crystals and compositions.
- maltitol was only presented only in the form of low-rich syrups.
- maltitol was marketed as amorphous and impure powders.
- maltitol compositions having no defects flow, caking, dissolution, or compression presented by known maltitol powders.
- the invention relates to modified maltitol crystals, characterized by the fact that they are of bipyramidal form including two regular tetrahedrons juxtaposed by their base of square section of approximately 50 to 500 ⁇ m per side, constituting thus regular octahedra of about 50 to 500 ⁇ m in edge length.
- the invention relates also modified maltitol crystals, characterized by the fact that they are prismatic in shape ending by plane faces constituting a tetrahedron, and that they have a length of 100 to 400 ⁇ m and a width of about 20 to 100 ⁇ m.
- a prismatic form is more compressible and allows an impasto (solidification) at low crystal content, sometimes sought after (pasta chewing, chewing gum centers to be coated).
- the invention therefore relates first of all to the crystals bipyramidal and prismatic illustrated in Figures 1 to 4.
- the crystals were observed under a tension of 2 and 5 kV. Photographs are captured on the microscope with a magnification of 350 times (figures 1), of 500 times (figure 2), 50 times (figure 3) and 200 times (figure 4) then enlarged when printing. However, a scale remains inscribed on the photograph and thus indicates the real size of the crystals.
- the crystals in Figures 1 and 2 are shaped massive, bipyramidal. More specifically, they have the form of two regular tretrahedrons, juxtaposed by their base of square section, about 50 to 500 ⁇ m per side, constituting thus regular octahedra of about 50 to 500 ⁇ m in edge length.
- FIG. 3 shows that the crystals conforming to the invention are not agglomerated or organized into small bundles agglutinated but are on the contrary well dissociated and individualized in relation to each other.
- the crystal of Figure 4 appears as a stick ending in a point. Specifically, it has a shape prismatic whose length is greater than the width (approximately 5 times greater than the width), ending with flat faces constituting a tetrahedron. This rod has a length of approximately 100 to 400 ⁇ m over a width of about 20 to 100 ⁇ m.
- maltitol compositions according to the invention are crystallized, which gives them a very high stability against humidity. They have by therefore a slight tendency to bulk up or motter. Also, their use is easy and it is not imperative to take drastic measures to prevent this risk.
- crystalline maltitol compositions have all a richness in maltitol greater than or equal to 87%, preferably greater than or equal to 92%, and more preferably greater than or equal to 96%, and advantageously a reduced content of 1,6-maltosyl maltitol.
- maltitol when the crystal composition of maltitol is made up of maltitol crystals bipyramidal, it has a maltotriitol content, in weight on dry matter, less than 1%.
- maltitol When the crystalline composition of maltitol is made of prismatic maltitol crystals, it has a maltotriitol content, by weight over dry matter, greater than or equal to 4%.
- maltitol when the crystalline composition of maltitol is made up of both maltitol crystals bipyramidal and prismatic, it presents a maltotriitol content, by weight on dry matter, included between 1 and 4%.
- Carbohydrates can be polyols such as in particular sorbitol, maltotriitol and maltotetraitol.
- Compliant maltitol crystal compositions to the invention may contain, without their presence significantly alters the crystallinity of these compositions, certain substances such as for example intense sweeteners, colors, pigments, perfumes, aromas, vitamins, minerals, trace elements, pharmaceutical active ingredients or veterinary, fatty acid esters, acids organic or mineral and their salts, materials proteins like proteins, amino acids and enzymes.
- certain substances such as for example intense sweeteners, colors, pigments, perfumes, aromas, vitamins, minerals, trace elements, pharmaceutical active ingredients or veterinary, fatty acid esters, acids organic or mineral and their salts, materials proteins like proteins, amino acids and enzymes.
- the crystalline maltitol compositions are likely to be obtained by crystallization of a syrup maltitol with a higher maltitol content or equal to 87%, preferably greater than or equal to 92% and more preferably greater than or equal to 96% and a maltotriitol content which, depending on the composition wants to obtain, is less than 1%, between 1 and 4%, or more than 4% by weight on dry matter.
- One of the essential characteristics of the invention is therefore to vary the contents of maltotriitol maltitol syrups to crystallize while now advantageously reduced content of 1,6-maltosyl maltitol.
- the invention also relates to a process for orienting the shape of the maltitol crystals, characterized by the fact that it consists in controlling the content in maltotriitol maltitol syrup to crystallize. This checking the maltotriitol content of maltitol syrup to be crystallized can be carried out upstream and / or downstream of the crystallization stage.
- the first step of the process is known per se. She consists in liquefying a starch milk whose origin botanical can be arbitrary: it can come from wheat, corn or potato for example.
- This starch milk is supplemented with acid in the case of a so-called acid liquefaction, or of an ⁇ -amylase in the case of an enzymatic liquefaction.
- the liquefaction stage is carried out in two sub-stages, the first consisting in heating, for a few minutes and at a temperature between 105 and 108 ° C., the starch milk in the presence of an ⁇ -amylase. (TERMAMYL R 120L type sold by the company NOVO) and a calcium-based activator, the second consisting in heating the starch milk thus treated at a temperature between 95 and 100 ° C for one to two hours.
- ⁇ -amylase ⁇ -amylase
- ⁇ -amylase proceeds to inhibit ⁇ -amylase.
- This inhibition of the ⁇ -amylase can preferably be done thermally, by carrying out a thermal shock at the liquefaction outlet a few seconds at a temperature greater than or equal at 130 ° C.
- the saccharification step is then carried out.
- the liquefied starch milk is first of all subjected to the action of a maltogenic ⁇ -amylase, such as that sold by the company NOVO, under the name Maltogenase R.
- the maltogenic ⁇ -amylase can be added all at once or several times.
- This addition of debranching enzyme can be done at when adding the maltogenic ⁇ -amylase or when adding ⁇ -amylase.
- This debranching enzyme is chosen from the group consisting of pullulanases and isoamylases.
- the pullulanase is, for example, that sold by the company ABM under the name PULLUZYME R.
- the isoamylase is, for example, that marketed by the company HAYASHIBARA.
- the method is implemented in presence of isoamylase for which the applicant company found that it not only provided a maltose syrup with more maltose content high than using a pullulanase, but also to get a maltose syrup with a reduced content of maltosyl-1,6 maltose and therefore maltosyl-1,6 maltitol after hydrogenation.
- the saccharification stage can be carried out also totally or partially in the presence of ⁇ -amylase fungal.
- ⁇ -amylase which generally improves subsequent filtration steps.
- the quantities and conditions of action of the different enzymes used in the liquefaction and saccharification stages of starch milk are usually those that are recommended for starch hydrolysis and are well known to humans of career.
- maltose hydrolyzate contains at least 87%, preferably at least 92%, and more preferably at minus 96% by weight of maltose.
- the hydrolyzate thus saccharified is then filtered. on pre-layer filter or by microfiltration on membranes, then demineralized.
- This molecular sieving step can consist, for example, in a chromatographic separation step or in a separation step on membranes.
- the chromatographic fractionation step is carried out in a manner known per se, discontinuously or continuous (simulated moving bed), on adsorbents of the type cationic resins, or on strongly acidic zeolites, preferentially charged using alkaline ions or alkaline earth such as calcium or magnesium but more preferably using sodium ions.
- membranes of different pore diameters are made from many polymers and copolymers of the type polysulfones, polyamides, polyacrylonitrates, polycarbonates, polyfurans, etc.
- the maltose hydrolyzate thus obtained can then be easily catalytically hydrogenated.
- the hydrogen pressure used is generally understood between 30 and 60 bars and the temperature at which it takes place the hydrogenation is between 100 and 150 ° C.
- the reaction is stopped when the content of the medium reaction in reducing sugars has become less than 1%, preferably still less than 0.5% and more particularly less than 0.1%.
- the reaction medium After the reaction medium has cooled, remove the catalyst by filtration and demineralize the maltitol syrup thus obtained on cationic resins and anionic. At this point, the syrups contain at least 85% maltitol.
- the syrup to be crystallized is concentrated to 80% of dry matter, placed in a laboratory crystallizer and temperature stabilized at 50 ° C, then a primer of MALTISORB R (crystallized maltitol marketed by the Applicant) at a rate of 1% / dry matter , is added and the crystallizer is cooled with slow stirring to 20 ° C, at a rate of 0.3 ° C per hour. After turbination and ethanol clearing, the crystals are dried and observed under a scanning electron microscope.
- MALTISORB R crystallizer is cooled with slow stirring to 20 ° C, at a rate of 0.3 ° C per hour.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
- les figures 1 et 2 représentent des photographies au microscope électronique à balayage de cristaux de forme bipyramidale conforme à l'invention ;
- la figure 3 représente une photographie au microscope électronique à balayage à moindre grossissement de cristaux identiques à ceux des figures 1 et 2 ;
- la figure 4 représente une photographie au microscope électronique à balayage d'un cristal de forme prismatique conforme à l'invention.
- soit de cristaux bipyramidaux conformes à l'invention ;
- soit de cristaux prismatiques conformes à l'invention ;
- soit à la fois de cristaux bipyramidaux et prismatiques.
- au niveau de la fabrication du sirop de maltose en mettant en oeuvre des enzymes hydrolysant le maltotriose, et/ou
- en effectuant un tamisage moléculaire du sirop de maltose destiné à être hydrogéné puis cristallisé, et/ou
- en effectuant un tamisage moléculaire du sirop de maltitol destiné à être cristallisé, et/ou
- en effectuant une hydrolyse enzymatique du sirop de maltitol destiné à être cristallisé.
- en redissolvant la composition cristalline de maltitol dans l'eau et en effectuant un tamisage moléculaire sur le sirop ainsi obtenu et/ou une hydrolyse enzymatique, et/ou
- en redis solvant la composition cristalline de maltitol dans l'eau et en y ajoutant les quantités de maltotriitol nécessaires pour obtenir, après recristallisation, une nouvelle composition cristalline de maltitol conforme à l'invention présentant la teneur désirée en maltotriitol.
- soit une première fraction enrichie en maltose et oligosaccharides supérieurs et une seconde fraction enrichie en glucose ;
- soit une première fraction enrichie en oligosaccharides supérieurs et une seconde fraction enrichie en maltose et glucose ;
- soit, enfin, une première fraction enrichie en oligosaccharides supérieurs, une deuxième fraction enrichie en maltose et une troisième fraction enrichie en glucose.
- effectuer éventuellement un fractionnement chromatographique, connu en soi, de manière à obtenir une fraction riche en maltitol et une fraction plus ou moins riche en maltotriitol en fonction de la forme des cristaux désirée ;
- concentrer la fraction riche en maltitol ;
- cristalliser et séparer les cristaux de maltitol formés ;
- recycler les eaux-mères de cristallisation en amont de l'étape de fractionnement chromatographique.
- concentrer le sirop de maltitol ;
- cristalliser et séparer les cristaux de maltitol formés.
- effectuer éventuellement une hydrolyse enzymatique du sirop de maltitol, au moyen par exemple d'une amyloglucosidase immobilisée ou non de manière à transformer le maltotriitol éventuellement présent en maltitol ;
- concentrer le sirop de maltitol ainsi obtenu ;
- cristalliser et séparer les cristaux de maltitol formés.
- effectuer éventuellement un fractionnement chromatographique, connu en soi, de manière à obtenir une fraction riche en maltose et plus ou moins riche en maltotriose ;
- hydrogéner la fraction riche en maltose ;
- cristalliser et séparer les cristaux de maltitol formés.
| COMPOSITION | ASPECT DES CRISTAUX |
| DP2H > 99 % | homogènes, de forme bipyramidale |
| DP2H : 93,5 % | hétérogènes, de formes |
| DP3H : 3,8 % | bipyramidale et |
| Sup. : 2,7 % | prismatique |
| DP1H : 5,2 % | |
| DP2H : 90,1 % | homogènes, |
| DP3H : 0,9 % | de forme bipyramidale |
| DP4H : 3,8 % | |
| DP2H : 96 % | homogènes, de forme |
| DP3H : 4 % | prismatique |
| DP1H = sorbitol | |
| DP2H = maltitol | |
| DP3H = maltotriitol | |
| DP4H = maltotétraitol | |
| Sup. = maltotétraitol et homologues supérieurs |
Claims (10)
- Cristaux de maltitol modifiés, caractérisés par le fait qu'ils sont de forme bipyramidale comprenant deux tétraèdres réguliers juxtaposés par leur base de section carrée de 50 à 500 µm environ de côté, constituant ainsi des octaèdres réguliers d'environ 50 à 500 µm de longueur d'arête.
- Composition cristalline de maltitol, caractérisée par le fait qu'elle comprend essentiellement des cristaux de maltitol conformes à la revendication 1 et qu'elle présente une richesse en maltitol supérieure ou égale à 87 %, de préférence supérieure ou égale à 92 %, et plus préférentiellement supérieure ou égale à 96 % et une teneur en maltotriitol, en poids sur matière sèche, inférieure à 1 %.
- Procédé de fabrication d'une composition selon la revendication 2, caractérisé par le fait qu'il consiste à cristalliser un sirop de maltitol présentant une richesse en maltitol supérieure ou égale à 87 %, de préférence supérieure ou égale à 92 %, et plus préférentiellement supérieure ou égale à 96 % et une teneur en maltotriitol inférieure 1 % en poids sur matière sèche.
- Cristaux de maltitol modifiés, caractérisés par le fait qu'ils sont de forme prismatique, se terminant par des faces planes constituant un tétraèdre, et qu'ils ont une longueur de 100 à 400 µm et une largeur d'environ 20 à 100 µm.
- Composition cristalline de maltitol, caractérisée par le fait qu'elle comprend essentiellement des cristaux de maltitol conformes à la revendication 4 et qu'elle présente une richesse en maltitol supérieure ou égale à 87 %, de préférence supérieure ou égale à 92 %, et plus préférentiellement supérieure ou égale à 96 % et une teneur en maltotriitol supérieure ou égale à 4 %.
- Procédé de fabrication d'une composition selon la revendication 5, caractérisé par le fait qu'il consiste à cristalliser un sirop de maltitol présentant une richesse en maltitol supérieure ou égale à 87 %, de préférence supérieure ou égale à 92 %, et plus préférentiellement supérieure ou égale à 96 % et une teneur en maltotriitol supérieure ou égale à 4 % en poids sur matière sèche.
- Composition cristalline de maltitol, caractérisée par le fait qu'elle comprend des cristaux de maltitol conformes aux revendications 1 et 4 et qu'elle présente une richesse en maltitol supérieure ou égale à 87 %, de préférence supérieure ou égale à 92 %, et plus préférentiellement supérieure ou égale à 96 % et une teneur en maltotriitol, en poids sur matière sèche, comprise entre 1 et 4 %.
- Procédé de fabrication d'une composition selon la revendication 7, caractérisé par le fait qu'il consiste à cristalliser un sirop de maltitol présentant une richesse en maltitol supérieure ou égale à 87 %, de préférence supérieure ou égale à 92 %, et plus préférentiellement supérieure ou égale à 96 % et en teneur en maltotriitol, en poids sur matière sèche, comprise entre 1 et 4 %.
- Procédé pour orienter la forme des cristaux de maltitol, caractérisé par le fait qu'il consiste à contrôler la teneur en maltotriitol du sirop de maltitol à cristalliser.
- Utilisation de maltotriitol pour modifier ou contrôler la forme des cristaux de maltitol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9712035A FR2769025B1 (fr) | 1997-09-26 | 1997-09-26 | Cristaux de maltitol de formes particulieres, compositions cristallines les contenant et procedes pour leur preparation |
| FR9712035 | 1997-09-26 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP0905138A1 true EP0905138A1 (fr) | 1999-03-31 |
| EP0905138B1 EP0905138B1 (fr) | 2002-11-13 |
| EP0905138B2 EP0905138B2 (fr) | 2008-07-23 |
Family
ID=9511538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98402334A Expired - Lifetime EP0905138B2 (fr) | 1997-09-26 | 1998-09-23 | Cristaux de maltitol de formes particulières, compositions cristallines les contenant et procédés pour leur préparation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6344591B2 (fr) |
| EP (1) | EP0905138B2 (fr) |
| JP (1) | JP4005240B2 (fr) |
| KR (1) | KR100480446B1 (fr) |
| AT (1) | ATE227732T1 (fr) |
| AU (1) | AU761172B2 (fr) |
| BR (1) | BR9803949A (fr) |
| CA (1) | CA2247526C (fr) |
| DE (1) | DE69809362T3 (fr) |
| DK (1) | DK0905138T4 (fr) |
| ES (1) | ES2186989T5 (fr) |
| FR (1) | FR2769025B1 (fr) |
| PT (1) | PT905138E (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2055197A1 (fr) | 2007-10-30 | 2009-05-06 | Roquette Freres | Procédé d'évapocristallisation du maltitol |
| KR20090063150A (ko) * | 2007-12-12 | 2009-06-17 | 로께뜨프레르 | 장방형 평행육면체 말티톨 |
| WO2011027061A1 (fr) | 2009-09-01 | 2011-03-10 | Roquette Freres | Procede de remplacement total ou partiel du talc dans les chewing-gums |
| US11987828B2 (en) | 2015-07-06 | 2024-05-21 | Roquette Freres | Method for producing maltitol, with an increased yield |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458401B1 (en) * | 2000-11-15 | 2002-10-01 | Roquette Freres | Process for producing a powder containing crystalline particles of maltitol |
| WO2005014608A2 (fr) * | 2003-07-18 | 2005-02-17 | Cargill Incorporated | Procede de preparation de produits enrichis en maltitol |
| DE102004038689A1 (de) * | 2004-08-10 | 2006-03-02 | Südzucker AG Mannheim/Ochsenfurt | Organoleptisch verbesserte besonders lagerstabile Hartkaramellen |
| WO2006022206A1 (fr) | 2004-08-25 | 2006-03-02 | Towa Chemical Industry Co., Ltd. | Poudre de maltitol cristallin moins sujette à consolidation et procédé de fabrication de celle-ci |
| CN102321126B (zh) * | 2011-09-08 | 2014-07-09 | 天津大学 | 一种制备麦芽糖醇晶体的方法 |
| KR101408092B1 (ko) * | 2013-02-19 | 2014-06-19 | 주식회사 고영테크놀러지 | 마그네틱 브레이크 |
| CN112602809B (zh) * | 2020-12-09 | 2023-03-31 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种脆筒内喷用无蔗糖巧克力组合物及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4408041A (en) * | 1981-02-12 | 1983-10-04 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Anhydrous crystals of maltitol and the whole crystalline hydrogenated starch hydrolysate mixture solid containing the crystals, and process for the production and uses thereof |
| EP0202165A1 (fr) * | 1985-05-15 | 1986-11-20 | Roquette FrÀ¨res | Procédé et installation de production de maltitol cristallisé |
| EP0735042A1 (fr) * | 1995-03-29 | 1996-10-02 | Roquette Freres | Composition de maltitol et son procédé de préparation |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4861665A (fr) | 1971-12-03 | 1973-08-29 | ||
| JPS5029029B2 (fr) | 1972-04-17 | 1975-09-19 | ||
| JPS4987619A (fr) | 1972-12-27 | 1974-08-22 | ||
| JPS49110620A (fr) | 1973-03-08 | 1974-10-22 | ||
| US3918986A (en) | 1973-06-21 | 1975-11-11 | Nikken Chemicals Co Ltd | Composite maltitol powder |
| JPS5025514A (fr) | 1973-07-07 | 1975-03-18 | ||
| JPS5059312A (fr) | 1973-10-02 | 1975-05-22 | ||
| JPS50129769A (fr) | 1974-04-05 | 1975-10-14 | ||
| JPS51113813A (en) | 1975-03-03 | 1976-10-07 | Towa Kasei Kogyo Kk | Pulverizing process of maltitol |
| US4248895A (en) | 1978-12-21 | 1981-02-03 | Life Savers, Inc. | Dehydrated higher polyalcohols, comestibles and chewing gum containing same and method |
| JPS5858145A (ja) | 1981-10-05 | 1983-04-06 | Tanabe Seiyaku Co Ltd | 速放性マイクロカプセル |
| US4511654A (en) | 1982-03-19 | 1985-04-16 | Uop Inc. | Production of high sugar syrups |
| US4429122A (en) | 1982-04-20 | 1984-01-31 | Uop Inc. | Separation of saccharides |
| FR2575179B1 (fr) † | 1984-12-20 | 1987-02-06 | Roquette Freres | Procede de preparation de maltitol cristallise |
| FR2575180B1 (fr) | 1984-12-20 | 1987-02-06 | Roquette Freres | Produit a haute teneur en maltitol, ses applications et son procede de fabrication |
| FR2588005B1 (fr) | 1985-10-02 | 1987-12-11 | Roquette Freres | Maltitol poudre directement compressible et son procede de preparation |
| JP2696537B2 (ja) † | 1988-10-28 | 1998-01-14 | 東和化成工業株式会社 | 高純度マルトースの製造方法 |
| US5583215A (en) † | 1990-06-25 | 1996-12-10 | Towa Chemical Industry Co., Ltd. | Crystalline mixture solid containing maltitol and a process for preparing it |
| DE69310968T2 (de) * | 1992-03-17 | 1997-09-04 | Ueno Seiyaku Oyo Kenkyujo Kk | Verfahren zur Herstellung von pulverförmigem kristallinem Maltitol |
| DK114893D0 (fr) | 1993-10-14 | 1993-10-14 | Novo Nordisk As | |
| FR2714796B1 (fr) † | 1994-01-10 | 1996-03-08 | Roquette Freres | Confiserie grainée et procédé de fabrication de ladite confiserie. |
| FR2732343B1 (fr) † | 1995-03-29 | 1997-06-13 | Roquette Freres | Composition de maltitol et son procede de preparation |
| JP3602903B2 (ja) † | 1995-05-02 | 2004-12-15 | 東和化成工業株式会社 | 結晶マルチトール及びそれを含有する含蜜結晶の製造方法 |
| KR100197354B1 (ko) * | 1995-06-28 | 1999-06-15 | 김영환 | 클럭 위상을 이용한 캐리증가 가산기 |
-
1997
- 1997-09-26 FR FR9712035A patent/FR2769025B1/fr not_active Expired - Lifetime
-
1998
- 1998-09-09 CA CA002247526A patent/CA2247526C/fr not_active Expired - Lifetime
- 1998-09-23 ES ES98402334T patent/ES2186989T5/es not_active Expired - Lifetime
- 1998-09-23 DE DE69809362T patent/DE69809362T3/de not_active Expired - Lifetime
- 1998-09-23 PT PT98402334T patent/PT905138E/pt unknown
- 1998-09-23 EP EP98402334A patent/EP0905138B2/fr not_active Expired - Lifetime
- 1998-09-23 DK DK98402334T patent/DK0905138T4/da active
- 1998-09-23 AT AT98402334T patent/ATE227732T1/de active
- 1998-09-24 BR BR9803949-0A patent/BR9803949A/pt not_active Application Discontinuation
- 1998-09-25 JP JP30940598A patent/JP4005240B2/ja not_active Expired - Lifetime
- 1998-09-25 KR KR10-1998-0040009A patent/KR100480446B1/ko not_active Expired - Lifetime
- 1998-09-25 US US09/160,133 patent/US6344591B2/en not_active Expired - Lifetime
- 1998-09-25 AU AU87048/98A patent/AU761172B2/en not_active Expired
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4408041A (en) * | 1981-02-12 | 1983-10-04 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Anhydrous crystals of maltitol and the whole crystalline hydrogenated starch hydrolysate mixture solid containing the crystals, and process for the production and uses thereof |
| EP0202165A1 (fr) * | 1985-05-15 | 1986-11-20 | Roquette FrÀ¨res | Procédé et installation de production de maltitol cristallisé |
| EP0735042A1 (fr) * | 1995-03-29 | 1996-10-02 | Roquette Freres | Composition de maltitol et son procédé de préparation |
Non-Patent Citations (1)
| Title |
|---|
| S. OHNO, ET AL.: "X-Ray crystal structure of maltitol (4-O-alpha-D-glucopyranosyl-D-Glucitol)", CARBOHYDRATE RESEARCH, vol. 108, 1 January 1982 (1982-01-01), AMSTERDAM, NL, pages 163 - 171, XP000572365 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2055197A1 (fr) | 2007-10-30 | 2009-05-06 | Roquette Freres | Procédé d'évapocristallisation du maltitol |
| US8012263B2 (en) | 2007-10-30 | 2011-09-06 | Roquette Freres | Process for the evapocrystallization of maltitol |
| KR20090063150A (ko) * | 2007-12-12 | 2009-06-17 | 로께뜨프레르 | 장방형 평행육면체 말티톨 |
| FR2925058A1 (fr) * | 2007-12-12 | 2009-06-19 | Roquette Freres | Maltitol parallelepipede rectangulaire. |
| EP2093231A1 (fr) | 2007-12-12 | 2009-08-26 | Roquette Freres | Maltitol parallelepipede rectangulaire |
| US9938313B2 (en) | 2007-12-12 | 2018-04-10 | Roquette Freres | Rectangular parallelepipedal maltitol |
| WO2011027061A1 (fr) | 2009-09-01 | 2011-03-10 | Roquette Freres | Procede de remplacement total ou partiel du talc dans les chewing-gums |
| WO2011027062A1 (fr) | 2009-09-01 | 2011-03-10 | Roquette Freres | Procede d'obtention de chewing-gums par remplacement du talc par des agglomerats de cristaux |
| US11987828B2 (en) | 2015-07-06 | 2024-05-21 | Roquette Freres | Method for producing maltitol, with an increased yield |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2247526A1 (fr) | 1999-03-26 |
| EP0905138B1 (fr) | 2002-11-13 |
| JP4005240B2 (ja) | 2007-11-07 |
| ES2186989T3 (es) | 2003-05-16 |
| BR9803949A (pt) | 1999-12-21 |
| US20010006956A1 (en) | 2001-07-05 |
| US6344591B2 (en) | 2002-02-05 |
| CA2247526C (fr) | 2007-05-08 |
| FR2769025A1 (fr) | 1999-04-02 |
| PT905138E (pt) | 2003-03-31 |
| AU761172B2 (en) | 2003-05-29 |
| FR2769025B1 (fr) | 1999-12-03 |
| JPH11263796A (ja) | 1999-09-28 |
| AU8704898A (en) | 1999-04-15 |
| DE69809362T3 (de) | 2009-04-16 |
| DE69809362T2 (de) | 2003-09-11 |
| KR19990030165A (ko) | 1999-04-26 |
| DE69809362D1 (de) | 2002-12-19 |
| DK0905138T3 (da) | 2003-03-10 |
| DK0905138T4 (da) | 2008-11-24 |
| ES2186989T5 (es) | 2008-12-16 |
| ATE227732T1 (de) | 2002-11-15 |
| KR100480446B1 (ko) | 2005-06-20 |
| EP0905138B2 (fr) | 2008-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0185595B2 (fr) | Procédé de préparation d'un produit à haute teneur en maltitol et applications de ce produit | |
| EP0905138B1 (fr) | Cristaux de maltitol de formes particulières, compositions cristallines les contenant et procédés pour leur préparation | |
| EP3565656B1 (fr) | Procédé de fabrication de cristaux de d-allulose | |
| EP1016728B1 (fr) | Procédé de fabrication d'un sirop riche en maltose | |
| EP1350436B1 (fr) | Composition liquide de maltitol, son procédé de fabrication et ses utilisations | |
| EP0593368A1 (fr) | Polymère soluble hypocalorique du glucose et procédé de préparation de ce polymère | |
| CA2248439C (fr) | Procede de fabrication d'un sirop riche en maltose | |
| FR2705207A1 (fr) | Procédé de dragéification dure sans sucre et produits ainsi obtenus. | |
| EP2624709B1 (fr) | Procede de fabrication de sirops de sorbitol de haute purete a partir de saccharose et utilisations | |
| EP3387020B1 (fr) | Hydrolysat d'amidon de basse viscosite presentant un comportement a la retrogradation ameliore | |
| FR2553791A1 (fr) | Procede de production de maltose en poudre cristalline et produit obtenu | |
| EP3155095B1 (fr) | Procede de fabrication d'une solution aqueuse stable de bêta-amylase, solution aqueuse obtenue et ses utilisations | |
| EP1041156A1 (fr) | Procédé de fabrication d'un hydrolysat d'amidon à haute teneur en dextrose | |
| EP2093231B1 (fr) | Cristaux de maltitol de forme parallélépipèderectangulaire | |
| EP0988323A1 (fr) | Polysaccharides acariogenes et procede de fabrication de ces polysaccharides | |
| EP0832899B1 (fr) | Composition de lactitol et son procédé de préparation | |
| CA2293195A1 (fr) | .alpha.-amylase maltogenique immobilisee et son utilisation dans la fabrication d'un sirop riche en maltose | |
| EP1041155A1 (fr) | Procédé de fabrication d'un hydrolysat d'amidon à haute teneur en dextrose | |
| FR2791703A1 (fr) | Procede de preparation d'un dextrose cristallin alpha anhydre de haute purete | |
| WO2008029033A1 (fr) | Procédé d'obtention d'un sirop à haute teneur en maltitol | |
| EP0580490B1 (fr) | Procédé de fabrication de mannitol | |
| EP0661930A1 (fr) | Compositions liquides visqueuses de xylitol et leur procede de preparation | |
| EP3320090B1 (fr) | Procede de fabrication de maltitol presentant un rendement ameliore |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IT LI NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| 17P | Request for examination filed |
Effective date: 19990331 |
|
| AKX | Designation fees paid |
Free format text: AT BE CH DE DK ES FI FR GB GR IT LI NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20010710 |
|
| GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
| GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IT LI NL PT SE |
|
| REF | Corresponds to: |
Ref document number: 227732 Country of ref document: AT Date of ref document: 20021115 Kind code of ref document: T |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REF | Corresponds to: |
Ref document number: 69809362 Country of ref document: DE Date of ref document: 20021219 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: KELLER & PARTNER PATENTANWAELTE AG |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
| GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20030221 |
|
| REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20030400458 Country of ref document: GR |
|
| REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20030212 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2186989 Country of ref document: ES Kind code of ref document: T3 |
|
| PLBQ | Unpublished change to opponent data |
Free format text: ORIGINAL CODE: EPIDOS OPPO |
|
| PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
| PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
| 26 | Opposition filed |
Opponent name: DANISCO SWEETENERS OY Effective date: 20030812 |
|
| NLR1 | Nl: opposition has been filed with the epo |
Opponent name: DANISCO SWEETENERS OY |
|
| PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
| PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
| PLBB | Reply of patent proprietor to notice(s) of opposition received |
Free format text: ORIGINAL CODE: EPIDOSNOBS3 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: RT |
|
| APBP | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2O |
|
| APAH | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNO |
|
| APBQ | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3O |
|
| APBU | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9O |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: S72 |
|
| PUAH | Patent maintained in amended form |
Free format text: ORIGINAL CODE: 0009272 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT MAINTAINED AS AMENDED |
|
| 27A | Patent maintained in amended form |
Effective date: 20080723 |
|
| AK | Designated contracting states |
Kind code of ref document: B2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IT LI NL PT SE |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: AEN Free format text: BREVET MAINTENU DANS UNE FORME MODIFIEE |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20080531 |
|
| NLR2 | Nl: decision of opposition |
Effective date: 20080723 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071001 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20060928 Year of fee payment: 9 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: RPEO |
|
| REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20080402766 Country of ref document: GR |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T4 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: DC2A Date of ref document: 20080930 Kind code of ref document: T5 |
|
| NLR3 | Nl: receipt of modified translations in the netherlands language after an opposition procedure | ||
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20100930 Year of fee payment: 13 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20110923 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110923 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: S72Z Free format text: PATENT REVOKED - APPEAL DISMISSED; APPEAL LODGED ON 14 SEPTEMBER 2009, DISMISSED BY COURT ORDER DATED 11 OCTOBER 2010. PATENT REVOKED. (HC08C00711). |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY Effective date: 20101011 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: NEW ADDRESS: EIGERSTRASSE 2 POSTFACH, 3000 BERN 14 (CH) |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20170911 Year of fee payment: 20 Ref country code: IT Payment date: 20170918 Year of fee payment: 20 Ref country code: FI Payment date: 20170825 Year of fee payment: 20 Ref country code: CH Payment date: 20170915 Year of fee payment: 20 Ref country code: GR Payment date: 20170830 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20170912 Year of fee payment: 20 Ref country code: BE Payment date: 20170920 Year of fee payment: 20 Ref country code: DK Payment date: 20170823 Year of fee payment: 20 Ref country code: AT Payment date: 20170825 Year of fee payment: 20 Ref country code: NL Payment date: 20170816 Year of fee payment: 20 Ref country code: PT Payment date: 20170818 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20171016 Year of fee payment: 20 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69809362 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: EUP Effective date: 20180923 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MK Effective date: 20180922 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MK Effective date: 20180923 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK07 Ref document number: 227732 Country of ref document: AT Kind code of ref document: T Effective date: 20180923 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20181003 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20200901 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20180924 |